4//SEC Filing
SCHIERMEIER ANDREW 4
Accession 0001209191-19-044238
CIK 0001652130other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:15 PM ET
Size
5.5 KB
Accession
0001209191-19-044238
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy
Transactions
- Award
Stock Option (Right to Buy)
2019-08-01+55,000→ 55,000 totalExercise: $18.09Exp: 2029-07-31→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]This option was granted on August 1, 2019 with respect to 55,000 shares of Common Stock, with 25% vesting on August 1, 2020 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001738456
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:15 PM ET
- Size
- 5.5 KB